SCHEMBL8097581

SCHEMBL8097581

C[C@H](CO)NC(=O)Nc1ccc(-c2nc(N)cc(C3(S(=O)(=O)c4ccccc4)CC3)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.38
KDM4E B2RXH2 3/20 0.38
HTT P42858 1/20 0.38
CA12 O43570 3/20 0.37
CA1 P00915 3/20 0.37
CA2 P00918 3/20 0.37
CA9 Q16790 3/20 0.37
PIK3CD O00329 4/20 0.35
ROCK2 O75116 4/20 0.35
ROCK1 Q13464 4/20 0.35
MEN1 O00255 3/20 0.35
ALDH1A1 P00352 3/20 0.35
HPGD P15428 3/20 0.35
KMT2A Q03164 3/20 0.35
PIK3CA P42336 1/20 0.35
NAMPT P43490 2/20 0.35
CYP2C9 P11712 1/20 0.35
GHSR Q92847 1/20 0.35
NPSR1 Q6W5P4 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8098658 0.97 MAPT (0.37) MAPTKDM4EHTTCA12CA1
SCHEMBL8098657 0.97 MAPT (0.37) MAPTKDM4EHTTCA12CA1
SCHEMBL8106295 0.91 CA12 (0.42) MAPTKDM4EHTTCA12CA1
SCHEMBL8092462 0.88 PIK3CA (0.38) CA12CA1CA2CA9PIK3CD
SCHEMBL8091845 0.88 PIK3CA (0.38) CA12CA1CA2CA9PIK3CD
SCHEMBL8097177 0.88 PIK3CD (0.39) CA12CA1CA2CA9PIK3CD
SCHEMBL8090246 0.86 PIK3CA (0.42) MAPTKDM4EHTTPIK3CDMEN1
SCHEMBL8096233 0.84 PIK3CD (0.40) MAPTKDM4EHTTPIK3CDMEN1
SCHEMBL8091937 0.84 CA12 (0.39) CA12CA1CA2CA9PIK3CD
SCHEMBL8098832 0.84 MAPT (0.37) MAPTKDM4EHTTCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009007748-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed